You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 8,187,556


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,187,556
Title:Methods and kits for aseptic filing of products
Abstract: This invention relates to new methods & kits that minimize the risks and challenges associated with sterilization of multi-component medical devices.
Inventor(s): Kadiyala; Sudhakar (Raynham, MA)
Assignee: DePuy Spine, Inc. (Raynham, MA)
Application Number:13/172,808
Patent Claims:1. A kit comprising: a) a sterilized carrier enclosed in a sterilized housing comprising an inlet port; and b) a source of biologic agent capable of being filter sterilized for addition to the carrier through the port, wherein the inlet port comprises a microporous filter comprising pores no larger than 0.22 microns.

2. The kit of claim 1 wherein the housing is made from a material selected from the group consisting of polymeric and metallic materials.

3. The kit of claim 1, wherein the carrier is a biocompatible carrier.

4. The kit of claim 1, wherein the carrier comprises a bioabsorbable material.

5. The kit of claim 4, wherein the bioabsorbable material is a synthetic material.

6. The kit of claim 5, wherein the synthetic material is selected from the group consisting of polymers and copolymers of polyesters of [alpha]-hydroxycarboxylic acids, poly(L-lactide) (PLLA), polyglycolide (PGA), self-reinforced PLLA, self-reinforced PGA, poly-p-dioxanone, polyhydroxy acids, poly(ortho esters), poly(beta-hydroxybutyrate) (PHB), poly (PHB-hydroxyvaleric acid), pseudo-poly(aminoacids), polyiminocarbonates, poly(glycolide-co-trimethylene carbonate), polycaprolactone (PCL), polyvinyl alcohol (PVA), polyethylene oxide (PEO), and mixtures thereof.

7. The kit of claim 4, wherein the bioabsorbable material is a natural material.

8. The kit of claim 7, wherein the natural material is selected from the group consisting of collagen, recombinant collagen, laminin, elastin, fibronectin, fibrinogen, thrombospondin, gelatin, polysaccharides, poly-1-amino acids, hyaluronic acid, cellulose, alginates, chondroitin sulfate, chitosan, chitin, keratin, silk, small intestine submucosa ("SIS"), and combinations thereof.

9. The kit of claim 1, wherein the housing is selected from the group consisting of polymeric and metallic materials.

10. The kit of claim 9, wherein the housing is a polymeric material selected from the group consisting of polycarbonates, polyolefins, polyesters, polyethylenes, and combinations thereof.

11. The kit of claim 10, wherein the biologic agent is from the TGF-.beta. superfamily.

12. The kit of claim 11, wherein the agent is a bone morphogenic protein.

13. The kit of claim 12, wherein the agent is rhGDF-5.

14. The kit of claim 12, wherein the agent is BMP-2.

15. The kit of claim 12, wherein the agent is BMP-7.

16. The kit of claim 12, wherein the agent is CDMP-1.

17. The kit of claim 12, wherein the agent is GDF-5.

18. The kit of claims 12, wherein the carrier is collagen based.

19. The kit of claim 12, wherein the carrier is SIS.

20. The kit of claim 12 wherein the agent is GDF-5 and the carrier is SIS.

21. The kit of claim 1, wherein the biologic agent is selected from the group consisting of chemotactic agents; therapeutic agents proteins, short chain peptides, active or inactive peptides, glycoproteins lipoproteins, cell attachment mediators, biologically active ligands, integrin binding sequence, ligands, growth and/or differentiation agents, epidermal growth factor, IGF-I, IGF-II, TGF-.beta. I-III, vascular endothelial growth factors, fibroblast growth factors, platelet derived growth factors, insulin-like growth factor, transforming growth factors, parathyroid hormone, parathyroid hormone related peptides, bFGF, TGF-.beta. superfamily factors, bone morphogenetic proteins, BMP-2, BMP-4, BMP-6, BMP-7, BMP-12, sonic hedgehog, GDF5, BMP-14, MP-52, rhGDF-5, CDMP-1, GDF-6, GDF-8, CDMP-2, CDMP-3, PDGF, tenascin-C, hyaluronic acid, chondroitin sulfate, fibronectin, decorin, thromboelastin, thrombin-derived peptides, heparin-binding domains, heparin, heparin sulfate, DNA fragments and DNA plasmids, (as sole constituents or when incorporated into appropriate vectors,) and mixtures thereof.

22. A kit comprising: a) a sterilizable carrier enclosed in a sterilizable housing comprising an inlet port; b) a source of biologic agent capable of being filter sterilized for addition to the carrier through the port, wherein the port contains a microporous filter comprising pores no larger than 0.22 microns.

23. The kit of claim 22, wherein the biologic agent is sterile.

24. The kit of claim 22, wherein the housing is selected from the group consisting of polymeric and metallic materials.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.